<DOC>
	<DOCNO>NCT00974753</DOCNO>
	<brief_summary>Evaluate efficacy ketorolac 0.5 % , topical non-steroidal anti-inflammatory drug ( NSAID ) , prevent macular edema epiretinal membrane surgery . Patients undergoing epiretinal membrane surgery increase risk macular swell adversely affect vision . Since post-intraocular surgery inflammation contribute factor macular swell loss vision , NSAID drop may able prevent minimize deleterious effect macular swell epiretinal membrane surgery .</brief_summary>
	<brief_title>Prophylactic Ketorolac Post Epiretinal Membrane Surgery</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>idiopathic epiretinal membrane diagnosis require membrane peel surgery proliferative diabetic retinopathy sickle cell retinopathy radiation retinopathy choroidal fold hypersensitivity allergy NSAIDs wet macular degeneration branch retinal vein occlusion ( BRVO ) central retinal vein occlusion ( CRVO ) complicate membrane peel surgery</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>epiretinal membrane</keyword>
</DOC>